These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8222121)

  • 1. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
    Schwinger RH; Böhm M; Müller-Ehmsen J; Uhlmann R; Schmidt U; Stäblein A; Uberfuhr P; Kreuzer E; Reichart B; Eissner HJ
    Circulation; 1993 Nov; 88(5 Pt 1):2267-76. PubMed ID: 8222121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inotropic interventions on the force-frequency relation in the human heart.
    Bavendiek U; Brixius K; Münch G; Zobel C; Müller-Ehmsen J; Schwinger RH
    Basic Res Cardiol; 1998; 93 Suppl 1():76-85. PubMed ID: 9833134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
    Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
    Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
    Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E
    J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
    Schwinger RH; Müller-Ehmsen J; Böhm M; Erdmann E
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1180-8. PubMed ID: 8786551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy.
    Schwinger RH; Böhm M; Erdmann E
    Am Heart J; 1992 Jan; 123(1):116-28. PubMed ID: 1309621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
    Müller-Ehmsen J; Brixius K; Schwinger RH
    J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na(+)-channel activators increase cardiac glycoside sensitivity in failing human myocardium.
    Schwinger RH; Böhm M; La Rosée K; Schmidt U; Schulz C; Erdmann E
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):554-61. PubMed ID: 1380598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
    Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
    Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium.
    Flesch M; Schwinger RH; Schiffer F; Frank K; Südkamp M; Kuhn-Regnier F; Arnold G; Böhm M
    Circulation; 1996 Sep; 94(5):992-1002. PubMed ID: 8790037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The failing human heart is unable to use the Frank-Starling mechanism.
    Schwinger RH; Böhm M; Koch A; Schmidt U; Morano I; Eissner HJ; Uberfuhr P; Reichart B; Erdmann E
    Circ Res; 1994 May; 74(5):959-69. PubMed ID: 8156643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gingerol, isoproterenol and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium.
    Maier LS; Schwan C; Schillinger W; Minami K; Schütt U; Pieske B
    Cardiovasc Res; 2000 Mar; 45(4):913-24. PubMed ID: 10728417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of forskolin on the force-frequency behavior in nonfailing and end-stage failing human myocardium.
    Pieske B; Trost S; Schütt K; Minami K; Just H; Hasenfuss G
    Basic Res Cardiol; 1998; 93 Suppl 1():66-75. PubMed ID: 9833133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered inotropism in the failing human myocardium.
    Bavendiek U; Brixius K; Frank K; Reuter H; Pietsch M; Gross A; Müller-Ehmsen J; Erdmann E; Schwinger RH
    Basic Res Cardiol; 1996; 91 Suppl 2():9-16. PubMed ID: 8957538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure.
    Böhm M; La Rosée K; Schmidt U; Schulz C; Schwinger RH; Erdmann E
    Clin Investig; 1992 May; 70(5):421-5. PubMed ID: 1600353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na+ channel modulation and force-frequency relationship in human myocardium.
    Müller-Ehmsen J; Brixius K; Schulze C; Schwinger RH
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):727-32. PubMed ID: 9205957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced sensitivity of the failing human myocardium to cardiac glycosides and Na(+)-channel activators.
    Schwinger RH; Müller-Ehmsen J; Frank K; Koch A; Erdmann E
    Am Heart J; 1996 May; 131(5):988-93. PubMed ID: 8615321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
    Uhlmann R; Schwinger RH; Lues I; Erdmann E
    Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
    Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.